Announcements Trials

Browse Landscape

Phase

Status

Completed 34 Unknown 5 Withdrawn 3 Terminated 3 Recruiting 3 Not yet recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 846 Carcinoma, Non-Small-Cell Lung 553 Neoplasms 516 Prostatic Neoplasms 503 Lung Neoplasms 312 Colorectal Neoplasms 304 Multiple Myeloma 295 Neoplasm Metastasis 255 Melanoma 244 Ovarian Neoplasms 215 Leukemia, Myeloid, Acute 212 Pancreatic Neoplasms 203 Squamous Cell Carcinoma of Head and Neck 171 Carcinoma, Renal Cell 166 Stomach Neoplasms 160 Recurrence 159 Lymphoma 159 Carcinoma, Hepatocellular 159 Glioblastoma 151 Brain Neoplasms 151 Lymphoma, Non-Hodgkin 143 Uterine Cervical Neoplasms 142 Head and Neck Neoplasms 141 Urinary Bladder Neoplasms 137 Leukemia, Lymphocytic, Chronic, B-Cell 137 Triple Negative Breast Neoplasms 136 Precursor Cell Lymphoblastic Leukemia-Lymphoma 132 Hematologic Neoplasms 117 Colonic Neoplasms 117 Lymphoma, Follicular 114

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Fever × Clear all

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡